Medical News

RSS

Better use of quality-of-care ratings can lead to greater consumer control

A hospital pneumonia survival rate of 93 percent may sound good, but knowing that it's actually merely "fair" can help people pick a better hospital, according to new research. A "good" survival rate would be from 95 percent to 98 percent, medical experts say.

11 Sep 2009

Social identity has a positive impact on health and well-being

The quality of a person's social life could have an even greater impact than diet and exercise on their health and well-being. There is growing evidence that being a member of a social group can significantly reduce the risk of conditions like stroke, dementia and even the common cold.

11 Sep 2009

Students do not comply with basic preventative measures to combat H1N1

As public health experts warn of potential widespread outbreaks of H1N1 flu this school year, a new study from North Carolina State University shows that students do not comply with basic preventative measures as much as they think do. In other words, the kids aren't washing their hands.

11 Sep 2009

NeuroMetrix completes private placement of common stock and warrants

NeuroMetrix, Inc., today announced that it has completed its private placement of common stock and warrants. Gross proceeds from the offering were approximately $18.7 million.

11 Sep 2009

Democrats and Republicans take action, offer more reactions the day after President Obama's speech

Republicans are continuing to react to President Obama's Wednesday night speech while Democrats are counting votes and meeting with key groups within the caucus.

11 Sep 2009

Low self-esteem in children may lead to adult obesity

Previous research has shown that low self-esteem and emotional problems are found in people who are overweight or obese- but not which influences which. Research published today in the open access journal BMC Medicine, sheds light on this issue showing that children with emotional difficulties are at higher risk for obesity in adult life.

11 Sep 2009

SafeTrace Tx software deployed in Schuylkill Health of Pottsville

Global Med Technologies((R)), Inc. ("Global Med" or the "Company"), an international e-Health, medical information technology company, today announced that its Wyndgate Technologies division has licensed and deployed its SafeTrace Tx((R)) transfusion management software to Schuylkill Health of Pottsville, Pennsylvania.

11 Sep 2009

Fau and MELK genes may help improve breast cancer diagnosis and treatment

Researchers at Keele University have identified two genes which may help improve the diagnosis and treatment of breast cancer patients.

11 Sep 2009

New software tool for the visually impaired

To give navigational "sight" to the blind, Dr. Lahav has invented a new software tool to help the blind navigate through unfamiliar places. It is connected to an existing joystick, a 3-D haptic device, that interfaces with the user through the sense of touch.

11 Sep 2009

Blood collection professionals honored as part of the 5th Annual Blood Collectors Week

Blood collection professionals will be recognized in communities worldwide September 13-19, 2009, as part of the 5th Annual Blood Collectors Week, sponsored jointly by Fenwal, Inc. and AABB (formerly known as the American Association of Blood Banks). During the week, blood centers across the country will host celebrations, often with local government officials, to recognize their staffs and donors.

11 Sep 2009

Obama highlights new uninsured census numbers during meeting with nurses

Almost 6 million more Americans were uninsured during the last year when the economy worsened, President Obama, citing new census data, told a group of nurses at the White House on Thursday, the New York Times reports.

11 Sep 2009

BDMS declares quarterly cash dividend of 17 cents per share of common stock

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices announced its regular quarterly dividend. The Company's board of directors has declared a quarterly cash dividend of 17 cents per share of common stock. The dividend is payable October 9, 2009, to shareholders of record September 25, 2009.

10 Sep 2009

Phase II human clinical trial of Exsulin commences

Exsulin Corporation today announced the start of a phase II human clinical trial of Exsulin, a peptide drug product aimed at restoring insulin production in people with diabetes mellitus. The randomized, controlled 12-week trial in patients with established Type 1 diabetes (T1DM) will be co-led by Mayo Clinic in Rochester, Minn., and McGill University Health Centre in Montreal, Canada.

10 Sep 2009

Phase 2b clinical trial results of TC-5214 to be presented at nAChR2009

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, today confirmed plans to present data from its completed Phase 2b clinical trial of TC-5214 as an augmentation treatment for major depressive disorder at the Nicotinic Acetylcholine Receptors as Therapeutic Targets Symposium (nAChR2009) in Lincolnshire, Illinois on October 15, 2009.

10 Sep 2009

TrKA and CCM2 combination results in pediatric tumour regression

Why are some pediatric cancers able to spontaneously regress? Prof. Michael Fainzilber and his team of the Weizmann Institute's Biological Chemistry Department seem to have unexpectedly found part of the answer. Further research towards a better understanding of the mechanism of action might hopefully lead, in the future, to the development of drugs that will be able to induce regression of certain tumors.

10 Sep 2009

CytRx granted patent for molecular chaperone amplifier drug candidate

CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that it has been granted a key patent by the European Patent Office that covers through 2024 the use of its orally available molecular chaperone amplifier drug candidate arimoclomol for the treatment or prevention of neurodegenerative diseases of the central nervous system (CNS).

10 Sep 2009

Abbott to acquire Evalve for $410 million

Abbott announced today a definitive agreement to acquire the outstanding equity of Evalve, Inc., the global leader in the development of devices for minimally invasive repair of cardiac mitral valves.

10 Sep 2009

FDA approves Supplemental New Drug Application for DOXIL

Centocor Ortho Biotech Products, L.P. today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its Supplemental New Drug Application (sNDA) for DOXIL (doxorubicin HCI liposome injection) in combination with docetaxel for the treatment of women with locally advanced and metastatic breast cancer.

10 Sep 2009

Scientist awarded grant to study the role of VENs in quick decision making

A scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has been awarded a $400,000 grant from the James S. McDonnell Foundation to help study a rare cell type that is believed to play a role in quick decision making and intuition. Abnormalities in this cell type have been seen in people suffering from autism and dementia.

10 Sep 2009

Vitro Diagnostics' novel stem cell technology for cancer treatment

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. With the passing of Senator Edward Kennedy from brain cancer, we are reminded of such aggressive cancers without effective treatment.

10 Sep 2009